CytomX Therapeutics, Inc. (CTMX)
5.66
-0.41
(-6.75%)
USD |
NASDAQ |
Feb 04, 15:54
CytomX Therapeutics Market Cap : 959.00M for Feb. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 542.68M |
| NovaBay Pharmaceuticals, Inc. | 118.60M |
| Palatin Technologies, Inc. | 14.59M |
| Theriva Biologics, Inc. | 5.975M |
| Oragenics, Inc. | 0.6169M |
Market Cap Related Metrics
| PE Ratio | 13.53 |
| PS Ratio | 5.745 |
| PEG Ratio | 0.0923 |
| Price to Book Value | 8.930 |
| Price | 5.66 |
| Earnings Yield | 7.39% |
| PEGY Ratio | 0.0923 |
| Operating PE Ratio | 28.20 |
| Normalized PE Ratio | 13.55 |